Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,426–7,450 of 7,816 matching trials · page 298 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
MRI to Measure Treatment With Antibiotics in Alzheimer's Disease NCT00692588 Runs in: Canada · 1 site |
NA other |
COMPLETED | 58 | St. Joseph's Healthcare Hamilton OTHER |
2011-04-06 |
|
Computerized Personal Interventions for Alzheimer's Patients NCT01329484 Reminiscence therapy; Cognitive training; No treatment Runs in: Israel · 2 sites |
NA other |
UNKNOWN | 159 | Shaare Zedek Medical Center OTHER |
2011-04-06 |
|
Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI NCT01329601 StaCog, stage specific cognitive Intervention; booklet based training Runs in: Germany · 1 site |
PHASE4 other |
UNKNOWN | 24 | University of Rostock OTHER |
2011-04-06 |
|
Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population NCT00547560 GSI-953 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 49 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2011-04-04 |
|
Study Evaluating The Coadministration of Begacestat And Donepezil NCT00959881 Donepezil plus placebo; Donepezil; Begacestat Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 47 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2011-04-04 |
|
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease NCT00096473 Donepezil hydrochloride Runs in: Australia; Canada; France; Ireland; United Kingdom; United States · 42 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 229 | Eisai Inc. INDUSTRY |
2011-04-01 |
|
Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease NCT00165737 Donepezil Hydrochloride Runs in: United States · 5 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 974 | Eisai Inc. INDUSTRY |
2011-04-01 |
|
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) NCT00230568 Aricept Runs in: United States · 35 sites |
PHASE4 other |
COMPLETED | 100 | Eisai Inc. INDUSTRY |
2011-04-01 |
|
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) NCT00293176 Donepezil Hydrochloride; Placebo Runs in: United States · 54 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 821 | Eisai Inc. INDUSTRY |
2011-04-01 |
|
Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia NCT00880347 Blood sampling Runs in: France · 21 sites |
NA other |
COMPLETED | 550 | Exonhit INDUSTRY |
2011-03-31 |
|
Non-Interventional Study With Aricept® Evess NCT00889603 Aricept® Evess Runs in: Romania · 12 sites |
NA other |
COMPLETED | 370 | Pfizer INDUSTRY |
2011-03-31 |
|
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease NCT00549601 Rivastigmine patch (4.6 mg/day switch to 9.5 mg/day); Rivastigmine ... Runs in: Spain · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 142 | Novartis INDUSTRY |
2011-03-24 |
|
A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test NCT01322373 Runs in: United States · 2 sites |
NA other |
UNKNOWN | 120 | Orasi Medical, Inc. INDUSTRY |
2011-03-24 |
|
An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease NCT01013610 LNK-754; Placebo Runs in: United States · 7 sites |
PHASE1 other |
COMPLETED | 110 | Link Medicine Corporation INDUSTRY |
2011-03-15 |
|
Alzheimer's Disease and Related Disorders NCT01315704 Drug intervention Runs in: France · 1 site |
NA other |
UNKNOWN | 700 | University Hospital, Angers OTHER_GOV |
2011-03-15 |
|
Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio) NCT01314638 Workshop balances Runs in: France · 1 site |
NA other |
UNKNOWN | 100 | University Hospital, Angers OTHER_GOV |
2011-03-14 |
|
Cooperative Huntington's Observational Research Trial NCT00313495 Runs in: Australia; Canada; United States · 52 sites |
NA other |
UNKNOWN | 5,000 | HP Therapeutics Foundation OTHER |
2011-03-07 |
|
Treatment of Apathy in Alzheimer's Disease With Modafinil NCT01172145 Modafinil; Placebo Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 22 | Brown University OTHER |
2011-03-04 |
|
Minocycline for HIV+ Cognitive Impairment in Uganda NCT00855062 minocycline; minocycline placebo capsule Runs in: Uganda · 1 site |
PHASE1|PHASE2 anti-inflammatory |
TERMINATED | 73 | Johns Hopkins University OTHER |
2011-02-25 |
|
Medication Management and Care of Demented Patients With Behavioral and Psychological Symptoms of Dementia in Taiwan: A Retrospective Pilot Study NCT01303367 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 200 | Taipei Medical University WanFang Hospital OTHER |
2011-02-24 |
|
Dementia Antipsychotics And Antidepressants Discontinuation Study NCT00594269 Risperidone; Escitalopram; Citalopram; Sertraline; Paroxetine Runs in: Norway · 8 sites |
PHASE4 other |
COMPLETED | 149 | Sykehuset Innlandet HF OTHER |
2011-02-23 |
|
AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients NCT00190372 Controlled diet; Self-hypnotic relaxation Runs in: France · 1 site |
NA other |
COMPLETED | 240 | Assistance Publique - Hôpitaux de Paris OTHER |
2011-02-17 |
|
Pharmacokinetic Comparisons of Two Donepezil Formulations NCT01297036 Donepezil, ODT 10 mg; Donepezil, 10 mg tablet Runs in: South Korea · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 22 | Korea University Anam Hospital OTHER |
2011-02-16 |
|
Alzheimer's Disease Reminiscence Quality of Life NCT01295957 reminiscence therapy; comparison group; control Runs in: Argentina · 1 site |
PHASE4 other |
COMPLETED | 135 | Universidad Nacional de Rosario OTHER |
2011-02-15 |
|
Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid NCT00987220 Placebo; donepezil (Aricept) Runs in: United States · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 12 | Pfizer INDUSTRY |
2011-02-14 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial